Real-world effectiveness and safety of aripiprazole augmentation therapy in patients with major depressive disorder.
CONCLUSIONS: Aripiprazole augmentation therapy appears to be effective and safe in Japanese patients with depression/depressive symptoms treated in everyday clinical practice, taking into account factors associated with achieving remission.
PMID: 30173568 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Abilify | Cymbalta | Depression | Japan Health | Lexapro | Mirtazapine | Paroxetine | Paxil | Research | Sertraline | Study | Zoloft